Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
The primary objective is to demonstrate the efficacy of a 28-day, twice-daily (BID) dosing regimen of TIP versus placebo, as measured by the relative change in forced expiratory volume at 1 second (FEV1) % predicted from baseline (week 1/cycle 1, day 1) to the end of cycle 1 dosing (week 5/cycle 1, day 28).
Critère d'inclusion
- pulmonary P aeruginosa infection in patient with cystic fibrosis